Daye is a gynecological health company that creates products and services for vaginal treatment.
Daye has raised $11.6M in total funding. The most recent round was Series A. The last funding was announced in October 2022.
Daye's investors include Index Ventures, Khosla Ventures, Salica, Kindred Capital, Google for Startups.
Daye is headquartered in London, United Kingdom.
Daye is a gynecological health company that creates products and services for vaginal treatment.
Daye is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Daye — Funding & Investors." VCBacked, October 26, 2022, https://www.vcbacked.co/company/daye. Accessed September 30, 2026.
VCBacked. (2022). Daye — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/daye
{{cite web |title=Daye — Funding & Investors |url=https://www.vcbacked.co/company/daye |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated